联泓新科(003022) - 2023 Q1 - 季度财报

Financial Performance - In Q1 2023, the company achieved operating revenue of CNY 1,576,009,466.45, a year-on-year increase of 1.31%[4] - The net profit attributable to shareholders was CNY 147,159,610.20, reflecting a year-on-year growth of 36.98%[4] - The company reported a basic earnings per share of CNY 0.11, up 37.50% from CNY 0.08 in the previous year[4] - The net profit for Q1 2023 was CNY 149,902,642.09, an increase of 38.3% compared to CNY 108,489,572.88 in Q1 2022[18] - The total operating profit for Q1 2023 was CNY 179,710,613.49, up from CNY 127,070,213.34 in the same period last year, reflecting a growth of 41.4%[18] - The total revenue from other income in Q1 2023 was CNY 139,220,110.75, significantly higher than CNY 73,599,594.27 in Q1 2022, marking an increase of 89.1%[18] - The company reported a total comprehensive income of CNY 149,902,642.09 for Q1 2023, compared to CNY 108,489,572.88 in the same period last year, indicating a growth of 38.3%[19] Cash Flow and Assets - The net cash flow from operating activities was CNY 98,506,299.75, a decrease of 49.69% compared to the same period last year[10] - The total cash inflow from operating activities was CNY 1,958,880,732.61, compared to CNY 2,307,369,378.15 in the previous year, indicating a decrease of 15.1%[21] - The total cash outflow from investing activities was CNY 433,709,675.20, compared to CNY 249,811,474.84 in the previous year, reflecting an increase of 73.5%[21] - The net cash flow from financing activities was CNY 641,819,930.45, a significant improvement from a net outflow of CNY 53,539,618.58 in Q1 2022[21] - The company reported a cash balance of approximately ¥2.78 billion as of March 31, 2023, an increase from ¥2.41 billion at the beginning of the year[15] - Current assets totaled CNY 4,311,448,340.36, an increase from CNY 3,697,646,766.74, representing a growth of approximately 16.5%[16] - Cash and cash equivalents at the end of Q1 2023 amounted to CNY 1,754,054,796.67, an increase from CNY 1,264,261,519.91 at the end of Q1 2022[21] Liabilities and Equity - Total liabilities increased significantly, with accounts payable rising by 132.13% to CNY 348,338,514.72[7] - Total liabilities increased to CNY 7,285,122,797.51 from CNY 6,680,924,666.72, reflecting a growth of approximately 9.0%[17] - Non-current liabilities rose to CNY 3,505,452,689.64 from CNY 3,176,552,333.62, indicating an increase of about 10.3%[17] - The company's equity attributable to shareholders increased to CNY 7,088,991,740.67 from CNY 6,936,453,369.35, reflecting a growth of about 2.2%[17] Investments and Projects - The company plans to raise funds through a targeted issuance of A-shares to strengthen its competitive advantage in new energy materials and biodegradable materials[13] - The "100,000 tons/year lithium battery materials - carbonate joint device project" is set to commence production soon, leveraging self-produced raw materials for competitive advantage[13] - The "20,000 tons/year ultra-high molecular weight polyethylene and 90,000 tons/year vinyl acetate joint device project" is a major project in Shandong, expected to be completed within 2023, enhancing the company's product offerings[14] - The "biodegradable materials polylactic acid project" is a key project in Jiangxi, scheduled for completion by the end of 2023, aimed at expanding the company's biodegradable materials business[14] - The company is advancing the "new energy materials and biodegradable materials integration project," with plans for completion in the first half of 2025[14] - The "electronic-grade high-purity special gas and lithium battery additive project" is expected to be completed in Q4 2023, marking a significant breakthrough in the electronic gas industry[14] Shareholder Information - The total number of common shareholders at the end of the reporting period is 72,901, with the largest shareholder, Lianhong Group Co., Ltd., holding 51.77% of shares, equating to 691,392,000 shares[11] - The top ten shareholders include significant stakes from state-owned and private entities, with China Academy of Sciences Holdings Co., Ltd. holding 25.27% of shares[11] Research and Development - Research and development expenses increased to CNY 73,749,422.79, a rise of 16.3% from CNY 63,375,466.74 in Q1 2022[18] Other Financial Metrics - Total operating costs for Q1 2023 amounted to CNY 1,531,940,642.51, compared to CNY 1,504,359,052.24 in the same period last year, indicating an increase of about 1.8%[17] - Accounts receivable decreased to CNY 151,436,516.71 from CNY 173,888,415.13, reflecting a reduction of approximately 12.9%[16] - Inventory increased to CNY 780,093,674.47, up from CNY 661,687,661.72, marking a rise of about 17.9%[16] - The company's weighted average return on equity was 2.10%, up from 1.68% in the previous year[4]